Task: Answer Verification
Input (English): Question: Does beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure worsen glycaemic control?
Answer: BB use did not worsen glycaemic control, lipid profile or albuminuria status in subjects with SHF and T2DM. Carvedilol significantly improved glycemic control in subjects with SHF and T2DM and this improvement was non significantly better than that obtained with bisoprolol. BB's should not be withheld from patients with T2DM and SHF.
Output (English): no